Repurposing ribosome-targeting antibiotics to overcome resistance to venetoclax in acute myeloid leukemia

被引：1
|
作者：
Sharon, David [1 ]
Chan, Steven M. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Dept Hematol & Med Oncol, Toronto, ON, Canada
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2020年 / 7卷 / 02期
基金：
加拿大健康研究院;
关键词：
Acute myeloid leukemia; BCL-2; inhibitor; drug resistance; integrated stress response; antibiotics; mitochondrial translation; ABT-199;
D O I：
10.1080/23723556.2020.1712182
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Venetoclax, a selective B-cell lymphoma 2 inhibitor, has shown promise in the treatment of acute myeloid leukemia. However, the development of drug resistance limits its clinical efficacy. In our study, we discovered that ribosome-targeting antibiotics can be repurposed to overcome venetoclax resistance in AML cells through activation of the integrated stress response.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia
    Przedborski, Michelle
    Sharon, David
    Cathelin, Severine
    Chan, Steven
    Kohandel, Mohammad
    PLOS COMPUTATIONAL BIOLOGY, 2022, 18 (09)
  • [2] Venetoclax Resistance in Acute Myeloid Leukemia
    Garciaz, Sylvain
    Hospital, Marie-Anne
    Collette, Yves
    Vey, Norbert
    CANCERS, 2024, 16 (06)
  • [3] The Mechanisms of Action of Ribosome-Targeting Peptide Antibiotics
    Polikanov, Yury S.
    Aleksashin, Nikolay A.
    Beckert, Bertrand
    Wilson, Daniel N.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2018, 5
  • [4] Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
    Xu, Xi
    Ma, Weiwei
    Qiu, Guo
    Xuan, Li
    He, Chong
    Zhang, Tian
    Wang, Jian
    Liu, Qifa
    BIOLOGY-BASEL, 2023, 12 (10):
  • [5] Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design
    Lin, Jinzhong
    Zhou, Dejian
    Steitz, Thomas A.
    Polikanov, Yury S.
    Gagnon, Matthieu G.
    ANNUAL REVIEW OF BIOCHEMISTRY, VOL 87, 2018, 87 : 451 - 478
  • [6] Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia
    Sharma, Priyanka
    Borthakur, Gautam
    CANCER DRUG RESISTANCE, 2023, 6 (03) : 567 - 589
  • [7] Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics
    Krawczyk, Szymon J.
    Lesniczak-Staszak, Marta
    Gowin, Ewelina
    Szaflarski, Witold
    BIOMOLECULES, 2024, 14 (10)
  • [8] Venetoclax in Acute Myeloid Leukemia
    Mihaila, Romeo G.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2023, 18 (01) : 11 - 28
  • [9] Targeting epigenetic mechanisms to overcome venetoclax resistance
    Prado, Gabriel
    Kaestner, Charlotte L.
    Licht, Jonathan D.
    Bennett, Richard L.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2021, 1868 (08):
  • [10] Valproic Acid Enhances Venetoclax Efficacy in Targeting Acute Myeloid Leukemia
    Kawakatsu, Renshi
    Tadagaki, Kenjiro
    Yamasaki, Kenta
    Kuwahara, Yasumichi
    Yoshida, Tatsushi
    DISEASES, 2025, 13 (01)
12345